These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 30465205)

  • 1. Cancer Exome-Based Identification of Tumor Neo-Antigens Using Mass Spectrometry.
    Kalaora S; Samuels Y
    Methods Mol Biol; 2019; 1884():203-214. PubMed ID: 30465205
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High-Throughput, Fast, and Sensitive Immunopeptidomics Sample Processing for Mass Spectrometry.
    Marino F; Chong C; Michaux J; Bassani-Sternberg M
    Methods Mol Biol; 2019; 1913():67-79. PubMed ID: 30666599
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of HLA peptidomics and whole exome sequencing to identify human immunogenic neo-antigens.
    Kalaora S; Barnea E; Merhavi-Shoham E; Qutob N; Teer JK; Shimony N; Schachter J; Rosenberg SA; Besser MJ; Admon A; Samuels Y
    Oncotarget; 2016 Feb; 7(5):5110-7. PubMed ID: 26819371
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High-Throughput Prediction of MHC Class I and II Neoantigens with MHCnuggets.
    Shao XM; Bhattacharya R; Huang J; Sivakumar IKA; Tokheim C; Zheng L; Hirsch D; Kaminow B; Omdahl A; Bonsack M; Riemer AB; Velculescu VE; Anagnostou V; Pagel KA; Karchin R
    Cancer Immunol Res; 2020 Mar; 8(3):396-408. PubMed ID: 31871119
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mass Spectrometry Based Immunopeptidomics for the Discovery of Cancer Neoantigens.
    Bassani-Sternberg M
    Methods Mol Biol; 2018; 1719():209-221. PubMed ID: 29476514
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proteomics Analysis of Colorectal Cancer Cells.
    Chauvin A; Boisvert FM
    Methods Mol Biol; 2018; 1765():155-166. PubMed ID: 29589306
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protocol for purification and identification of MHC class I immunopeptidome from cancer cell lines.
    Mohan SV; Datta KK; Ziegman R; Smith C; Gowda H
    STAR Protoc; 2021 Mar; 2(1):100385. PubMed ID: 33778779
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Purification and Identification of Naturally Presented MHC Class I and II Ligands.
    Nelde A; Kowalewski DJ; Stevanović S
    Methods Mol Biol; 2019; 1988():123-136. PubMed ID: 31147937
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HPLC and MS analysis for the identification and characterisation of peptides presented in the context of the non-classical human leukocytes antigen (HLA) class I molecule HLA-E.
    Millo E; Damonte G
    Curr Pharm Des; 2009; 15(28):3325-35. PubMed ID: 19860682
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Proteomic identification of an MHC-binding peptidome from pancreas and breast cancer cell lines.
    Antwi K; Hanavan PD; Myers CE; Ruiz YW; Thompson EJ; Lake DF
    Mol Immunol; 2009 Sep; 46(15):2931-7. PubMed ID: 19615748
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumor Immunity and Survival as a Function of Alternative Neopeptides in Human Cancer.
    Rech AJ; Balli D; Mantero A; Ishwaran H; Nathanson KL; Stanger BZ; Vonderheide RH
    Cancer Immunol Res; 2018 Mar; 6(3):276-287. PubMed ID: 29339376
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of HLA class I-binding peptides derived from unique cancer-associated proteins by mass spectrometric analysis.
    Kamata Y; Kuhara A; Iwamoto T; Hayashi K; Koido S; Kimura T; Egawa S; Homma S
    Anticancer Res; 2013 May; 33(5):1853-9. PubMed ID: 23645730
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ProGeo-neo: a customized proteogenomic workflow for neoantigen prediction and selection.
    Li Y; Wang G; Tan X; Ouyang J; Zhang M; Song X; Liu Q; Leng Q; Chen L; Xie L
    BMC Med Genomics; 2020 Apr; 13(Suppl 5):52. PubMed ID: 32241270
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Electrospray mass spectrometry for the identification of MHC class I-associated peptides expressed on cancer cells.
    Bonner PL; Lill JR; Hill S; Creaser CS; Rees RC
    J Immunol Methods; 2002 Apr; 262(1-2):5-19. PubMed ID: 11983215
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Two-dimensional nanoflow liquid chromatography-tandem mass spectrometry of proteins extracted from rice leaves and roots.
    Breci L; Haynes PA
    Methods Mol Biol; 2007; 355():249-66. PubMed ID: 17093316
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MHC class I-presented tumor antigens identified in ovarian cancer by immunoproteomic analysis are targets for T-cell responses against breast and ovarian cancer.
    Morse MA; Secord AA; Blackwell K; Hobeika AC; Sinnathamby G; Osada T; Hafner J; Philip M; Clay TM; Lyerly HK; Philip R
    Clin Cancer Res; 2011 May; 17(10):3408-19. PubMed ID: 21300761
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative assessment of MHC antigen expression in bladder and testis tumour biopsies and established urological tumour cell lines: the relevance of cytokine and gene transfection for correction of defective MHC antigens.
    Nouri AM; Symes MO
    Oncol Rep; 2000; 7(5):959-64. PubMed ID: 10948322
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Guidance Document: Validation of a High-Performance Liquid Chromatography-Tandem Mass Spectrometry Immunopeptidomics Assay for the Identification of HLA Class I Ligands Suitable for Pharmaceutical Therapies.
    Ghosh M; Gauger M; Marcu A; Nelde A; Denk M; Schuster H; Rammensee HG; Stevanović S
    Mol Cell Proteomics; 2020 Mar; 19(3):432-443. PubMed ID: 31937595
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vivo MHC class II presentation of cytosolic proteins revealed by rapid automated tandem mass spectrometry and functional analyses.
    Dongre AR; Kovats S; deRoos P; McCormack AL; Nakagawa T; Paharkova-Vatchkova V; Eng J; Caldwell H; Yates JR; Rudensky AY
    Eur J Immunol; 2001 May; 31(5):1485-94. PubMed ID: 11465105
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tumor antigens and proteomics from the point of view of the major histocompatibility complex peptides.
    Admon A; Barnea E; Ziv T
    Mol Cell Proteomics; 2003 Jun; 2(6):388-98. PubMed ID: 12821722
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.